Lower serum chloride concentrations are associated with increased risk of mortality in critically ill cirrhotic patients: an analysis of the MIMIC-III database
Abstract:Background
Cirrhosis can be complicated by electrolyte abnormalities, but the major focus has been concentrated on the clinical significance of serum sodium levels. Emerging studies have identified hypochloremia as an independent prognostic marker in patients with chronic heart failure and chronic kidney disease. The aim of this study was to investigate whether serum chloride levels were associated with mortality of critically ill cirrhotic patients.
Methods
… Show more
“…Accumulating evidence has shed light on the prognostic implications of altered serum chloride levels in multiple conditions, including decompensated cirrhosis, congestive heart failure, chronic kidney disease, hypertension and pulmonary hypertension. [9][10][11][12][13][14][15][16]22,23 that serum chloride provides more robust prognostic information in this population than serum sodium. Indeed, although sodium is a widely known mortality predictor in cirrhosis, it has limited prognostic value in ALF demonstrated by multiple previous studies.…”
Section: Discussionmentioning
confidence: 94%
“…It is, however, generally considered as a counterpart of serum sodium and has previously received little attention for its potential pathological roles. Accumulating evidence has shed light on the prognostic implications of altered serum chloride levels in multiple conditions, including decompensated cirrhosis, congestive heart failure, chronic kidney disease, hypertension and pulmonary hypertension 9–16,22,23 . Whether chloride plays a role in the prognosis and disease severity of ALF was previously unknown.…”
Section: Discussionmentioning
confidence: 99%
“…Emerging evidence has identified hypochloremia as a predictor for mortality in patients with congestive heart failure and chronic kidney disease 9–12 . More recently, hypochloremia was demonstrated to be an adverse prognostic factor independent of serum sodium in patients with decompensated cirrhosis 13–16 . Electrolyte derangements are frequently observed in the ALF population, with previous studies focused on hypophosphatemia and hyponatremia 17–19 .…”
Section: Introductionmentioning
confidence: 99%
“…[9][10][11][12] More recently, hypochloremia was demonstrated to be an adverse prognostic factor independent of serum sodium in patients with decompensated cirrhosis. [13][14][15][16] Electrolyte derangements are frequently observed in the ALF population, with previous studies focused on hypophosphatemia and hyponatremia. [17][18][19] However, very little is known about the prognostic value and clinical relevance of chloride perturbations in ALF patients.…”
Background and Aims
Emerging evidence has identified hypochloremia as an independent predictor for mortality in multiple conditions including cirrhosis. Acute liver failure (ALF) is frequently complicated by electrolyte abnormalities. We investigated the prognostic value of hypochloremia in a large cohort of ALF patients from North America.
Methods
The Acute Liver Failure Study Group (ALFSG) registry is a longitudinal cohort study involving 2588 ALF patients enrolled prospectively from 32 North American academic centres. The primary outcome was a composite of 21‐day all‐cause mortality or requirement for liver transplantation (death/LT).
Results
Patients with hypochloremia (<98 mEq/L) had a significantly higher 21‐day mortality rate (42.1%) compared with those with normal (27.5%) or high (>107 mEq/L) chloride (28.0%) (p < .001). There was lower transplant‐free cumulative survival in the hypochloremic group than in the normo‐ or hyper‐chloremic groups (log‐rank, χ2 24.2, p < .001). Serum chloride was inversely associated with the hazard of 21‐day death/LT with multivariable adjustment for known prognostic factors (adjusted hazard ratio [aHR]: 0.977; 95% CI: 0.969–0.985; p < .001). Adding chloride to the ALFSG Prognostic Index more accurately predicted risk of death/LT in 19% of patients (net reclassification improvement [NRI] = 0.19, 95% CI: 0.13–0.25) but underestimated the probability of transplant‐free survival in 34% of patients (NRI = −0.34, 95% CI: −0.39 to −0.28).
Conclusions
Hypochloremia is a novel independent adverse prognostic factor in ALF. A new ALFSG‐Cl Prognostic Index may improve the sensitivity to identify patients at risk for death without LT.
“…Accumulating evidence has shed light on the prognostic implications of altered serum chloride levels in multiple conditions, including decompensated cirrhosis, congestive heart failure, chronic kidney disease, hypertension and pulmonary hypertension. [9][10][11][12][13][14][15][16]22,23 that serum chloride provides more robust prognostic information in this population than serum sodium. Indeed, although sodium is a widely known mortality predictor in cirrhosis, it has limited prognostic value in ALF demonstrated by multiple previous studies.…”
Section: Discussionmentioning
confidence: 94%
“…It is, however, generally considered as a counterpart of serum sodium and has previously received little attention for its potential pathological roles. Accumulating evidence has shed light on the prognostic implications of altered serum chloride levels in multiple conditions, including decompensated cirrhosis, congestive heart failure, chronic kidney disease, hypertension and pulmonary hypertension 9–16,22,23 . Whether chloride plays a role in the prognosis and disease severity of ALF was previously unknown.…”
Section: Discussionmentioning
confidence: 99%
“…Emerging evidence has identified hypochloremia as a predictor for mortality in patients with congestive heart failure and chronic kidney disease 9–12 . More recently, hypochloremia was demonstrated to be an adverse prognostic factor independent of serum sodium in patients with decompensated cirrhosis 13–16 . Electrolyte derangements are frequently observed in the ALF population, with previous studies focused on hypophosphatemia and hyponatremia 17–19 .…”
Section: Introductionmentioning
confidence: 99%
“…[9][10][11][12] More recently, hypochloremia was demonstrated to be an adverse prognostic factor independent of serum sodium in patients with decompensated cirrhosis. [13][14][15][16] Electrolyte derangements are frequently observed in the ALF population, with previous studies focused on hypophosphatemia and hyponatremia. [17][18][19] However, very little is known about the prognostic value and clinical relevance of chloride perturbations in ALF patients.…”
Background and Aims
Emerging evidence has identified hypochloremia as an independent predictor for mortality in multiple conditions including cirrhosis. Acute liver failure (ALF) is frequently complicated by electrolyte abnormalities. We investigated the prognostic value of hypochloremia in a large cohort of ALF patients from North America.
Methods
The Acute Liver Failure Study Group (ALFSG) registry is a longitudinal cohort study involving 2588 ALF patients enrolled prospectively from 32 North American academic centres. The primary outcome was a composite of 21‐day all‐cause mortality or requirement for liver transplantation (death/LT).
Results
Patients with hypochloremia (<98 mEq/L) had a significantly higher 21‐day mortality rate (42.1%) compared with those with normal (27.5%) or high (>107 mEq/L) chloride (28.0%) (p < .001). There was lower transplant‐free cumulative survival in the hypochloremic group than in the normo‐ or hyper‐chloremic groups (log‐rank, χ2 24.2, p < .001). Serum chloride was inversely associated with the hazard of 21‐day death/LT with multivariable adjustment for known prognostic factors (adjusted hazard ratio [aHR]: 0.977; 95% CI: 0.969–0.985; p < .001). Adding chloride to the ALFSG Prognostic Index more accurately predicted risk of death/LT in 19% of patients (net reclassification improvement [NRI] = 0.19, 95% CI: 0.13–0.25) but underestimated the probability of transplant‐free survival in 34% of patients (NRI = −0.34, 95% CI: −0.39 to −0.28).
Conclusions
Hypochloremia is a novel independent adverse prognostic factor in ALF. A new ALFSG‐Cl Prognostic Index may improve the sensitivity to identify patients at risk for death without LT.
“…[18][19][20]. A severely reduced Cl − intake can have negative impacts such as chronic heart failure, chronic kidney disease, liver cirrhosis, and so on [21][22][23][24]. (4) Construction and building trades: Very elevated Cl − levels in cement raw materials will reduce the strength of concrete, corrode steel bars, affect the durability of the whole building, and severely affect project quality [25][26][27].…”
Section: Sources and Hazards Of Chloride Ionmentioning
The chloride ion (Cl−) is a type of anion which is commonly found in the environment and has important physiological functions and industrial uses. However, a high content of Cl− in water will do harm to the ecological environment, human health and industrial production. It is of great significance to strictly monitor the Cl− content in water. Following the recent development of society and industry, large amounts of domestic sewage and industrial sewage are discharged into the environment, which results in the water becoming seriously polluted by Cl−. The detection of Cl− has gradually become a research focus. This paper introduces the harm of Cl− pollution in the environment and summarizes various Cl− detection methods, including the volumetric method, spectrophotometry method, electrochemical method, ion chromatography, paper-based microfluidic technology, fluorescent molecular probe, and flow injection. The principle and application of each technology are described; their advantages, disadvantages, and applicability are discussed. To goal of this research is to find a more simple, rapid, environmental protection and strong anti-interference detection technology of Cl−.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.